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A fatty acid-binding protein was purified from male rat kidney by the method of Fujii et al. [(1987) Arch. Biochem. 
Biophys. 254, 552-558]. Based on the close similarity of amino acid composition and the identity of the amino acid 
sequence in the amino-terminal region, the fatty acid-binding protein was identified as ct2wglobulin, which is the major 
male-specific protein in rat urine. The amino-terminal residue of the isolated kidney protein corresponds to residue 10 
of ct2u-globulin, suggesting hat the protein has been proteolytically processed in the kidney. This fatty acid-binding 
protein could not be immunologically detected in female rat kidney. 
Fatty acid-binding protein; Globulin, ct2u-; Male-specific protein; (Rat, Kidney) 
1. INTRODUCTION 
Fatty acid-binding proteins constitute a family 
of abundant cytosolic proteins of low molecular 
masses and are capable of binding fatty acids and 
other organic anions [1]. They are thought o be 
responsible for intracellular transport, sequestra- 
tion and metabolism of long-chain fatty acids [2]. 
Indeed, these proteins are specifically distributed in
such tissues as liver, intestine and heart that are ac- 
tively involved in fatty acid metabolism [3]. FABPs 
from these three tissues have been extensively 
characterized [4-8]. The structural data accumu- 
lated have shown that FABPs are structurally 
related to one another and together with cytosolic 
proteins uch as cellular etinoid-binding proteins 
and peripheral nerve myelin P2 protein form a pro- 
tein superfamily [5-8]. 
Recently, a FABP has been isolated from male 
rat kidney [9,10]. This protein, termed 'kidney 
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FABP', has a molecular mass of 15.5 kDa, binds 
an equimolar mount of fatty acids and is distinct 
from the tissue-specific FABPs so far reported in 
terms of molecular size and amino acid composi- 
tion. Moreover, the expression of this protein has 
been shown to alter in response to drug-induced 
and genetic hypertension [10-12], suggesting that it 
plays an important role in renal fatty acid meta- 
bolism under pathological conditions as well as 
normal conditions. However, nothing is as yet 
known concerning its structure. 
We report here that kidney FABP purified from 
male rat kidney is identical with a2u-globulin, 
which is the major male-specific protein in adult rat 
urine. 
2. MATERIALS AND METHODS 
2.1. Materials 
[1-~4C]Palmitate (59 mCi/mmol) was purchased from New 
England Nuclear, Sephadex G-75 from Pharmacia Biotechno- 
logy, DE-52 ion-exchange r sin from Whatman, and acetoni- 
trile and TFA from Wako Pure Chemical. All other chemicals 
used were of analytical grade. Polyclonal rabbit anti-kidney 
FABP antibodies [9] were kindly supplied by Drs S. Fujii and H. 
Kawaguchi of Hokkaido University. 
2.2. Purification of kidney FABP 
Kidney FABP was purified from kidneys of male Wistar rats 
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as described by Fujii et al. [9]. Briefly, the kidney cytosolic frac- 
tion was subjected to Sephadex G-75 gel filtration, followed by 
DE-52 ion-exchange chromatography. The protein thus purified 
was further applied to a Toyo Soda ODS (octadecylsilica) 120T 
column (0.45 × 25 cm) pre-equilibrated with 1% acetonitrile in
0.1% TFA. The FABP was then eluted with a linear acetonitrile 
gradient (1-60%) in 0.1% TFA for 45 min at a flow rate of 1 
ml/min. This chromatography was necessary to remove minor 
contaminants. 
2.3. Amino acid analysis and sequencing 
Protein samples were hydrolyzed in vacuo with 5.7 N HC1 at 
I10°C for 21 h, and the hydrolysates were analyzed with a 
Hitachi 835 amino acid analyzer. Methionine a d cystine were 
determined after performic acid oxidation [13]. The determina- 
tion of tryptophan was conducted after hydrolysis with 5.7 N 
HC1 containing 4°7o thioglycolic acid [14]. The amino-terminal 
sequence of the FABP was determined by automated Edman 
degradation i an Applied Biosystem 470A gas-phase sequencer 
equipped with a 120A phenylthiohydantoin analyzer. 
2.4. Fatty acid-b&ding assay 
[IJ4C]Palmitic acid-binding activity of kidney FABP was 
measured by the method fGlatz et al. [15]; 1 nmol of protein 
was incubated with 4 nmol of radioactive palmitic acid. 
2.5. Other method 
Protein concentration was determined by amino acid 
analysis. Tricine SDS-PAGE was performed as described [16]; 
using separating gels containing 16.5°70 acrylamide. Protein 
bands were stained with Coomassie brilliant blue. Double- 
immunodiffusion tests were performed by the method of 
Ouchterlony [17]. 
3. RESULTS AND DISCUSSION 
According to the method of Fuji i  et al. [9], the 
cytosolic fraction of male rat kidney was subjected 
to Sephadex G-75 gel f i ltration, and the fraction 
containing proteins of low molecular masses 
00-20  kDa) were pooled. The pooled fractions 
were applied to a DE-52 column and elution was 
conducted with a linear NaC1 gradient (0-0.3 M). 
As shown in fig. 1, three protein peaks, termed P1, 
P2 and P3, were thereby eluted. Of these peaks, P1 
and P3 showed significant [14C]palmitate-binding 
activities. From its electrophoretic mobil ity (fig.2) 
and amino acid composit ion (not shown), the P1 
protein was thought to be similar to heart type 
FABP [7,8]. On the other hand, the P3 protein ex- 
hibited a lower palmitate-binding activity than the 
PI  protein and had a molecular mass of about 15.5 
kDa as estimated by SDS-PAGE (fig.2). After fur- 
ther purif ication by reversed-phase HPLC,  this 
protein formed a single precipitin line with an- 
tibodies to kidney FABP in Ouchterlony test (not 
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Fig.1. Separation f rat kidney low-molecular-mass protein on 
DE-52. The fractions containing proteins of low molecular 
masses 00-20 kDa) of the Sephadex G-75 column were applied 
to a DE-52 column (1.8 × l0 cm) and eluted with a linear N CI 
gradient (0-0.3 M). The horizontal lines marked P1, P2 and 3
denote the fractions which are pooled and stu ied further. The 
dashed lines indicate the specific-binding activity for palmitate 
of the pooled fractions. 
shown). Its amino acid composit ion was very 
similar to that reported for kidney FABP [10] 
(table 1). It was, therefore, certain that the P3 pro- 
tein was kidney FABP.  Although the palmitate- 
b inding activity of the P3 protein was lower than 
that reported for kidney FABP [9], this difference 
seems to be due to the difference in methodology. 
While we used Lipidex 5000 for the binding assay 
[15], the previous workers employed dextran- 
coated charcoal [9]. 
To obtain further structural informat ion con- 
cerning this kidney FABP,  its amino-terminal  
kDa 
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Fig.2. Tricine SDS-PAGE of P1 and P3 proteins of fig.l. 
Lanes: 1, P1 protein (5/~g); 2, P3 protein (5/~g). 
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1 10 20 
LDVAKLNGDWFS I VVASNKR ........... 
1 10 20 30 
Urine a2u-globul in  EEASSTRGNLDVAKLNGDWFS IVVASNKREK I 
Fig.3. Amino-terminal amino acid sequence of kidney FABP. The sequence of urine ~2u-globulin is based on the data reported in [19]. 
amino acid sequence was determined up to residue 
20. The sequence thus determined is: 
LDVAKLNGDWFSIVVASNKR.  A computer  
search for sequence similar ity in the Nat ional  
Biochemical  Research Foundat ion  Protein Se- 
quence Database showed that this amino-terminal  
sequence is identical with the sequence from 
residues l0 to 29 of  urine ce2o-globulin [18,19], as 
shown in fig.3. Furthermore,  it was found that the 
amino acid composi t ion of  k idney FABP is very 
similar to that of  the region spanning residues 
10-162 (carboxyl-terminus) of urine cezu-globulin 
(table 1). These results are in agreement with the 
Table 1 
Amino acid compositions of P3 protein, kidney FABP and 
oe2u-globulin 
Amino mol% 
acid P3 protein a Kidney oe2u-Globulin c 
FABP b 
Asp 13.5 11.7 13.9 
Thr 6.0 6.6 6.0 
Ser 4.0 4.4 4.0 
Glu 11.3 10.8 10.6 
Pro 0.9 0.8 0.7 
Gly 7.0 7.5 7.3 
Ala 3.9 4.4 4.0 
Cys 2.0 1.4 2.0 
Val 6.1 6.1 6.0 
Met 2.5 1.7 2.7 
lie 6.0 6.0 6.6 
Leu 9.3 9.1 9.3 
Tyr 4.3 4.7 4.6 
Phe 6.7 7.3 6.6 
Lys 8.7 8.1 8.6 
His 2.1 2.2 2.0 
Arg 5.1 6.3 5.9 
Trp 0.6 0.8 0.7 
a This study. Data based on an average of 
b Data from [101 
c Residues 10-162, data from [18,19] 
three hydrolysates 
report  of  Charles [20] that ce2u-globulin in rat 
k idney lacked the 9 amino-terminal  residues. A 
doub le - immunodi f fus ion  test using anti-rat kidney 
FABP ant ibodies howed further that this protein 
was present only in male, but not in female, rat 
k idney (fig.4). This is also consistent with the 
reported sex-difference in the expression of  azv-  
g lobul in  [21]. Taken together, it can be concluded 
that k idney FABP is identical with a, Eu-globulin 
f rom which the 9-residue amino-terminal  segment 
has been removed. 
o~2u-Globulin s a male-specif ic rat protein that is 
synthesized in liver under complex hormonal  con- 
trol ,  secreted into the b lood,  and excreted in the 
urine [22]. A l though cezu-globulin is also found in 
the cytoso! o f  male rat k idney [22], no mRNA for 
this protein can be detected in the kidney by 
Northern blot analysis [23]. It is, therefore, l ikely 
that urine c~zu-globulin s reabsorbed from urine in- 
to the renal tubular  cells, where it loses its 9-residue 
amino-terminal  segment by proteolyt ic processing. 
Fig.4. Double-immunodiffusion test. Wells: 1, rabbit antibody 
to rat kidney FABP; 2, male rat kidney cytosol; 3, female rat 
kidney cytosol. 
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cr2u-Globulin is a member of the oe2u-globulin 
( l igand-binding carrier) superfamily, which con- 
sists of more than a dozen proteins (mostly ex- 
tracellular) of low molecular masses [24]. Many of 
the members of this superfamily bind hydrophobic 
l igands and are thought to be involved in the 
transport  and metabol ism of the ligands (e.g. 
retinol for serum retinol-binding protein and 
cholesterol for apol ipoprotein D). However, no 
ligands for oe2u-globulin have as yet been reported, 
even though this protein is a representative of this 
superfamily. The results reported herein indicate 
that aEu-globulin serves as a carrier of fatty acids in 
the kidney. 
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